ClinVar Genomic variation as it relates to human health
NM_014625.4(NPHS2):c.502C>T (p.Arg168Cys)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_014625.4(NPHS2):c.502C>T (p.Arg168Cys)
Variation ID: 188952 Accession: VCV000188952.8
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 1q25.2 1: 179559711 (GRCh38) [ NCBI UCSC ] 1: 179528846 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Mar 29, 2015 Jun 23, 2024 Dec 4, 2023 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_014625.4:c.502C>T MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_055440.1:p.Arg168Cys missense NM_001297575.2:c.502C>T NP_001284504.1:p.Arg168Cys missense NC_000001.11:g.179559711G>A NC_000001.10:g.179528846G>A NG_007535.1:g.21239C>T LRG_887:g.21239C>T Q9NP85:p.Arg168Cys - Protein change
- R168C
- Other names
- -
- Canonical SPDI
- NC_000001.11:179559710:G:A
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
NPHS2 | - | - |
GRCh38 GRCh37 |
347 | 562 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic/Likely pathogenic (4) |
criteria provided, multiple submitters, no conflicts
|
Nov 17, 2023 | RCV000169326.7 | |
Pathogenic (1) |
criteria provided, single submitter
|
Dec 4, 2023 | RCV002515194.3 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Likely pathogenic
(Sep 02, 2014)
|
criteria provided, single submitter
Method: literature only
|
Nephrotic syndrome, idiopathic, steroid-resistant
(Autosomal recessive inheritance)
Affected status: unknown
Allele origin:
unknown
|
Counsyl
Accession: SCV000220661.2
First in ClinVar: Mar 29, 2015 Last updated: Dec 24, 2022 |
|
|
Likely pathogenic
(Apr 11, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Nephrotic syndrome, type 2
Affected status: no
Allele origin:
germline
|
Genome-Nilou Lab
Accession: SCV004049280.1
First in ClinVar: Oct 28, 2023 Last updated: Oct 28, 2023 |
|
|
Pathogenic
(Dec 04, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV003523922.2
First in ClinVar: Feb 07, 2023 Last updated: Feb 14, 2024 |
Comment:
This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 168 of the NPHS2 protein … (more)
This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 168 of the NPHS2 protein (p.Arg168Cys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with nephrotic syndrome (PMID: 15253708, 30721404, 32604935). ClinVar contains an entry for this variant (Variation ID: 188952). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt NPHS2 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects NPHS2 function (PMID: 14675423). This variant disrupts the p.Arg168 amino acid residue in NPHS2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 14675423, 15042551, 15059485, 26467726, 28385484). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. (less)
|
|
Pathogenic
(Nov 17, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Nephrotic syndrome, type 2
Affected status: unknown
Allele origin:
unknown
|
Baylor Genetics
Accession: SCV004191525.2
First in ClinVar: Dec 30, 2023 Last updated: Jun 17, 2024 |
|
|
Pathogenic
(-)
|
no assertion criteria provided
Method: clinical testing
|
Nephrotic syndrome, type 2
(Autosomal recessive inheritance)
Affected status: yes
Allele origin:
germline
|
Dr.Nikuei Genetic Center
Accession: SCV005061414.1
First in ClinVar: Jun 23, 2024 Last updated: Jun 23, 2024 |
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Genetic Study in Korean Pediatric Patients with Steroid-Resistant Nephrotic Syndrome or Focal Segmental Glomerulosclerosis. | Park E | Journal of clinical medicine | 2020 | PMID: 32604935 |
Genetics of congenital and infantile nephrotic syndrome. | Sharief SN | World journal of pediatrics : WJP | 2019 | PMID: 30721404 |
Genetic mutation in Egyptian children with steroid-resistant nephrotic syndrome. | Thomas MM | Journal of the Formosan Medical Association = Taiwan yi zhi | 2018 | PMID: 28385484 |
Analysis of the genes responsible for steroid-resistant nephrotic syndrome and/or focal segmental glomerulosclerosis in Japanese patients by whole-exome sequencing analysis. | Ogino D | Journal of human genetics | 2016 | PMID: 26467726 |
NPHS2 gene in steroid-resistant nephrotic syndrome: prevalence, clinical course, and mutational spectrum in South-West Iranian children. | Basiratnia M | Iranian journal of kidney diseases | 2013 | PMID: 24072147 |
Steroid-resistant nephrotic syndrome. | Kitamura A | Kidney international | 2008 | PMID: 18596732 |
NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence. | Weber S | Kidney international | 2004 | PMID: 15253708 |
[A novel mutation of NPHS2 identified in a Chinese family with steroid-resistant nephrotic syndrome]. | Yu ZH | Zhonghua er ke za zhi = Chinese journal of pediatrics | 2004 | PMID: 15059485 |
Infantile steroid-resistant nephrotic syndrome associated with double homozygous mutations of podocin. | Caridi G | American journal of kidney diseases : the official journal of the National Kidney Foundation | 2004 | PMID: 15042551 |
Plasma membrane targeting of podocin through the classical exocytic pathway: effect of NPHS2 mutations. | Roselli S | Traffic (Copenhagen, Denmark) | 2004 | PMID: 14675423 |
Text-mined citations for rs786204583 ...
HelpRecord last updated Sep 29, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.